DKP
AEON.WS

Davidson Kempner Partners’s AEON Biopharma Inc AEON.WS Stock Holding History

Davidson Kempner Partners’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$18.7K Buy
+366,671
New +$21.2K ﹤0.01% 287

Other funds holding AEON.WS

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Davidson Kempner Partners's AEON.WS Position: Q1 2023 in Review

Davidson Kempner Partners opened a new position in AEON Biopharma Inc (AEON.WS) in Q1 2023: 366,671 shares worth $18.7K. The stake represents ﹤0.01% of the portfolio and ranks #287 among its holdings.

49 funds tracked by Wall St. Rank hold AEON.WS as of Q1 2023.

  • Davidson Kempner Partners held 366,671 shares of AEON Biopharma Inc worth $18.7K as of Q1 2023.
  • AEON Biopharma Inc was a new Davidson Kempner Partners position in Q1 2023.
  • AEON Biopharma Inc made up ﹤0.01% of Davidson Kempner Partners's portfolio in Q1 2023, its #287 holding.
  • 49 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q1 2023.

Based on Davidson Kempner Partners's 13F filing for Q1 2023, filed 15 May 2023.